Schrodinger Inc (SDGR) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Schrodinger Inc stock (SDGR) is currently trading at $11.40. Schrodinger Inc PS ratio (Price-to-Sales) is 3.47. Analyst consensus price target for SDGR is $23.11. WallStSmart rates SDGR as Sell.
- SDGR PE ratio analysis and historical PE chart
- SDGR PS ratio (Price-to-Sales) history and trend
- SDGR intrinsic value — DCF, Graham Number, EPV models
- SDGR stock price prediction 2025 2026 2027 2028 2029 2030
- SDGR fair value vs current price
- SDGR insider transactions and insider buying
- Is SDGR undervalued or overvalued?
- Schrodinger Inc financial analysis — revenue, earnings, cash flow
- SDGR Piotroski F-Score and Altman Z-Score
- SDGR analyst price target and Smart Rating
Schrodinger Inc
📊 No data available
Try selecting a different time range
Smart Analysis
Schrodinger Inc (SDGR) · 8 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in institutional own.. Concerns around return on equity and operating margin. Significant fundamental concerns warrant caution or avoidance.
Schrodinger Inc (SDGR) Key Strengths (1)
107.73% of shares held by major funds and institutions
Supporting Valuation Data
Schrodinger Inc (SDGR) Areas to Watch (7)
Company is destroying shareholder value
Losing money on operations
Revenue declining -1.20%, a shrinking business
Company is losing money with a negative profit margin
Small-cap company with higher risk but more growth potential
Revenue is fairly priced at 3.47x sales
Fairly priced relative to book value
Schrodinger Inc (SDGR) Detailed Analysis Report
Overall Assessment
This company scores 26/100 in our Smart Analysis, earning a F grade. Out of 8 metrics analyzed, 1 register as strengths (avg 10.0/10) while 7 fall into concern territory (avg 2.4/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Institutional Own..
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Revenue Growth. Some valuation metrics including Price/Sales (3.47), Price/Book (2.44) suggest expensive pricing. Growth concerns include Revenue Growth at -1.20%, which may limit upside. Profitability pressure is visible in Return on Equity at -26.30%, Operating Margin at -19.70%, Profit Margin at -40.40%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -26.30% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -1.20% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
SDGR Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
SDGR's Price-to-Sales ratio of 3.47x trades at a deep discount to its historical average of 18.29x (0th percentile). The current valuation is 95% below its historical high of 63.82x set in Jun 2020, and 0% above its historical low of 3.47x in Mar 2026. Over the past 12 months, the PS ratio has compressed from ~6.2x as trailing revenue scaled faster than the stock price.
Compare SDGR with Competitors
Top HEALTH INFORMATION SERVICES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Schrodinger Inc (SDGR) · HEALTHCARE › HEALTH INFORMATION SERVICES
The Big Picture
Schrodinger Inc is in a turnaround phase, with management focused on restoring profitability. Revenue reached 256M with 1% decline year-over-year. The company is currently unprofitable, posting a -40.4% profit margin.
Key Findings
Spending 16% of revenue (41M) on R&D, reinforcing its commitment to innovation and future growth.
The company is unprofitable with a -40.4% profit margin. The path to breakeven will be the key catalyst.
Free cash flow is -16M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Volatility is elevated with a beta of 1.65, so expect amplified moves relative to the broader market.
Sector dynamics: monitor HEALTH INFORMATION SERVICES industry trends, competitive moves, and regulatory changes that could impact Schrodinger Inc.
Bottom Line
Schrodinger Inc is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(39 last 3 months)
| Insider | Type | Shares |
|---|---|---|
HERMAN, JENNY CAO | Sell | -608 |
| Insider | Type | Shares |
|---|---|---|
ABEL, ROBERT LORNE See Remarks | Sell | -1,300 |
| Insider | Type | Shares |
|---|---|---|
ABEL, ROBERT LORNE See Remarks | Sell | -1,230 |
Data sourced from SEC Form 4 filings
Last updated: 11:32:43 AM
About Schrodinger Inc(SDGR)
NASDAQ
HEALTHCARE
HEALTH INFORMATION SERVICES
USA
Schrdinger, Inc. provides a physics-based software platform that enables the discovery of novel molecules for drug development and material applications. The company is headquartered in New York, New York.